Diabetic cardiomyopathy--to take a long story serious

Bernd Stratmann1, Thomas Gawlowski, Diethelm Tschoepe

  • 1Heart and Diabetes Center NRW, Ruhr, University of Bochum, Bochum, Germany.

Herz
|May 15, 2010
PubMed

Insights

Diabetic cardiomyopathy, a distinct heart condition in type 2 diabetes, precedes heart failure. Understanding its molecular basis is key to early diagnosis and management.

Area of Science:

  • Cardiology
  • Endocrinology
  • Molecular Biology

Background:

  • Diabetic cardiomyopathy is a primary cardiac condition in type 2 diabetes, separate from coronary artery disease and hypertension.
  • A strong association exists between diabetes mellitus and heart failure, with altered cardiac structure and function common in type 2 diabetes patients.
  • Hyperglycemia and hyperlipidemia contribute to structural and functional damage in cardiac muscle and cardiomyocytes.

Purpose of the Study:

  • To review the mechanistic basis of diabetic cardiomyopathy in type 2 diabetes.
  • To explore the molecular pathways linking diabetes to cardiac dysfunction.
  • To highlight early diastolic dysfunction as a precursor to congestive heart failure.

Main Methods:

  • Literature review focusing on mechanistic and molecular studies.
  • Analysis of research on hyperglycemia, advanced glycation end products, and lipotoxicity.
  • Examination of diagnostic advancements for early cardiac dysfunction.

Main Results:

  • Diabetic cardiomyopathy is characterized by structural and functional cardiac changes.
  • Advanced glycation end products and lipotoxicity are key contributors to cardiac damage.
  • Early diastolic dysfunction is a sensitive indicator of developing congestive heart failure.

Conclusions:

  • Diabetic cardiomyopathy is a distinct disease process preceding heart failure in type 2 diabetes.
  • Understanding the molecular mechanisms is crucial for developing targeted therapies.
  • Early diagnosis of diastolic dysfunction can aid in preventing heart failure progression.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...